Clinical Trial Update: A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled trial of Cardene I.V. for pediatric hypertension was withdrawn from the study. No results were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Cardene I.V. (nicardipine)

Snippet

Sponsor: Facet Biotech | Conditions: Hypertension | Phase 2 | Status: WITHDRAWN